Clinical trial
A Randomized, Evaluator-Blinded, Phase 3 Study to Compare the Safety and Efficacy of PTK 0796 With Linezolid in the Treatment of Adults With Complicated Skin and Skin Structure Infection
NCT00865280 is registered in ClinicalTrials.gov with Paratek Pharmaceuticals Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Evaluator-Blinded, Phase 3 Study to Compare the Safety and Efficacy of PTK 0796 With Linezolid in the Treatment of Adults With Complicated Skin and Skin Structure Infection
- Lead sponsor
- Paratek Pharmaceuticals Inc
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- April 4, 2009
- Completion date
- April 15, 2010
- Enrollment
- 143 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.